A comparative study of the acceptability and effect of goserelin and nafarelin on endometriosis
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The effects of goserelin and nafarelin were compared in a prospective, randomized, open, parallel study of 6 months' treatment of 252 women with symptomatic, laparoscopically proven endometriosis. Twenty-eight departments of obstetrics and gynecology in Sweden, Norway, Denmark and Finland were included. Evaluations were made every 3 months for quantification of pain, bleeding and adverse events and convenience of treatment, and at 3 months after the end of treatment, when a control laparoscopy was performed for evaluation of changes in endometriotic lesion size, color and location. Thirty-nine patients withdrew and 113 women given goserelin and 100 women given nafarelin completed the study. There were no statistically significant differences between the groups, either in adverse events or in bleeding. There were no correlations between location, lesion size or type of lesion, and symptom score in either group, or between treatments with regard to change in endometriosis score. In both groups, the percentage of red and black lesions was reduced while the proportion of white lesions increased. The pain score was significantly reduced in both groups. Local irritation in the nasal mucosa was reported in both groups, mostly in the nafarelin-treated group. The goserelin-treated group also reported local symptoms at the injection site. We conclude that there is no statistically significant difference in treatment results or side-effects between goserelin and nafarelin when used for the treatment of endometriosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hormone treatment of endometriosis: The estrogenthreshold hypothesis
Barbieri, R. L. (1992) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(92)91706-g · Cited by 335
Effects of Triptorelin Versus Placebo on the Symptoms of Endometriosis
Bergqvist, A., Bergh, T., Hogström, L., Mattsson, S., Nordenskjöld, F., & Rasmussen, C. (1998) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00019-3 · Cited by 99
Self-citation
Cited by
Systematic review of endometriosis pain assessment: how to choose a scale?
Bourdel, N., Alves, J., Pickering, G., Ramilo, I., Roman, H., & Canis, M. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmu046 · Cited by 372
Reevaluating response and failure of medical treatment of endometriosis: a systematic review
Becker, C. M., Gattrell, W. T., Gude, K., & Singh, S. S. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.05.004 · Cited by 302
Medical management of endometriosis-associated pain
Mahutte, N. G., & Arici, A. (2003) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(02)00057-8 · Cited by 68
“There is no therapeutic advantage of one GnRH agonist over another [53,54].”
BackgroundGnRH analogs: Options for endometriosis-associated pain treatment
Batzer, F. R. (2006) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2006.07.007 · Cited by 42
Gonadotropin-releasing hormone analogues for endometriosis
Veth, V. B., van de Kar, M. M., Duffy, J. M., van Wely, M., Mijatovic, V., & Maas, J. W. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd014788.pub2 · Cited by 39
Metadata
- Authors
- Bergqvist, A.
- Venue
- Gynecological Endocrinology
- Publisher
- Informa UK Limited
- Published
- 2000-01
- Volume
- 14
- Issue
- 6
- Pages
- 425-432
- ISSN
- 0951-3590 (ISSN-L)
- 1473-0766
- OpenAlex
- W2126729416
- Cited by
- 25
- References
- 2
- FWCI
- 0.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A comparative study of the acceptability and effect of goserelin and nafarelin on endometriosis. https://app.cochat.ai/papers/10.3109/09513590009167714
- The paper
- Bergqvist, A. (2000). A comparative study of the acceptability and effect of goserelin and nafarelin on endometriosis. Gynecological Endocrinology. https://doi.org/10.3109/09513590009167714
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.